Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Does drinking water rich in hydrogen gas revive brain hypometabolism in neurodegeneration by SCFAs upregulation?

European Journal of Clinical Nutrition volume 75, pages 212–213 (2021)Cite this article

Subjects

Water infused with hydrogen gas (hydrogen-rich water, HRW) appeared recently as an innovative functional drink that may exhibit a number of benefits for human health [4]. Specifically, HRW has recently been advocated as a possible nutritional upregulator of SCFAs production by gut microbiota in three pre-clinical trials, all published from 2018 onward. Ad libitum consumption of HRW (hydrogen 0.32 mM) for 4 weeks induced a significant rise in the production of certain SCFAs (such as propionic acid, isobutyric acid, and isovaleric acid) in mouse cecal contents, as compared to the control mice which consumed normal water with no dissolved hydrogen [5]. Another study reported similar effects in piglets fed with a mycotoxin-contaminated diet [6], in which 25-day consumption of HRW (0.60 mM) augmented the levels of butyric acid, valeric acid, and total SCFAs in the large intestine. Finally, Bordoni et al. [7] have shown that 15-day treatment with HRW (0.4–0.9 mM) in an animal model of Parkinson’s disease elevated the levels of butyric acid in the feces by inducing a higher abundance of butyrate-producing bacteria (including Lachnospiraceae, Ruminococcaceae, and Papillibacter). Although promising, these preliminary studies have not addressed whether higher levels of gut flora-generated SCFAs after the treatment translate into improved brain bioenergetics. Nevertheless, a randomized, double-blind, parallel-group clinical trial reported ameliorated patient-reported disease rating scores in patients with levodopa-medicated Parkinson’s disease who drank 1000 mL per day of HRW for 48 weeks [8], suggesting that beneficial effects might be mediated by HRW-driven SCFAs output from the gut flora. These promising findings should be carefully interpreted since this pilot trial was rather small (e.g., nine patients received HRW and eight patients received placebo) and the authors have not tested SCFAs production or any other gut microbiome biomarker.

Before recommending water infused with hydrogen to the general public, further robust randomized controlled trials are obligatory, from deciphering possible metabolic role(s) of HRW-driven SCFAs as an alternative energy source for the human brain, to accounting for different HRW treatment protocols and dosing ranges, and pathophysiological features of neurodegenerative disorders. Although HRW is generally considered safe for human consumption [9] the safety surveillance also remains highly justified to detect any rare and/or long-term adverse events over a large patient population and prolonged time period.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Gut microbiota as a possible disease-modifying agent in neurodegenerative diseases.

References

  1. Zilberter Y, Zilberter M. The vicious circle of hypometabolism in neurodegenerative diseases: ways and mechanisms of metabolic correction. J Neurosci Res. 2017;95:2217–35. https://doi.org/10.1002/jnr.24064

    Article  CAS  PubMed  Google Scholar 

  2. Pathak D, Berthet A, Nakamura K. Energy failure: does it contribute to neurodegeneration? Ann Neurol. 2013;74:506–16. https://doi.org/10.1002/ana.24014

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms. Expert Rev Neurother. 2018;18:83–90. https://doi.org/10.1080/14737175.2018.1400909

    Article  CAS  PubMed  Google Scholar 

  4. Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol Ther. 2014;144:1–11. https://doi.org/10.1016/j.pharmthera.2014.04.006

    Article  CAS  PubMed  Google Scholar 

  5. Higashimura Y, Baba Y, Inoue R, Takagi T, Uchiyama K, Mizushima K, et al. Effects of molecular hydrogen-dissolved alkaline electrolyzed water on intestinal environment in mice. Med Gas Res. 2018;8:6–11. https://doi.org/10.4103/2045-9912.229597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zheng W, Ji X, Zhang Q, Yao W. Intestinal microbiota ecological response to oral administrations of hydrogen-rich water and lactulose in female piglets fed a Fusarium toxin-contaminated diet. Toxins. 2018;10:246. https://doi.org/10.3390/toxins10060246

    Article  CAS  PubMed Central  Google Scholar 

  7. Bordoni L, Gabbianelli R, Fedeli D, Fiorini D, Bergheim I, Jin CJ, et al. Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson’s disease. PLoS ONE. 2019;14:e0223238. https://doi.org/10.1371/journal.pone.0223238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yoritaka A, Takanashi M, Hirayama M, Nakahara T, Ohta S, Hattori N. Pilot study of H2 therapy in Parkinson’s disease: a randomized double-blind placebo-controlled trial. Mov Disord. 2013;28:836–9. https://doi.org/10.1002/mds.25375

    Article  CAS  PubMed  Google Scholar 

  9. Ohno K, Ito M, Ichihara M, Ito M. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev. 2012;2012:353152. https://doi.org/10.1155/2012/353152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. FSPE Applied Bioenergetics Lab, University of Novi Sad, Novi Sad, Serbia

    Sergej M. Ostojic

Authors
  1. Sergej M. Ostojic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sergej M. Ostojic.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ostojic, S.M. Does drinking water rich in hydrogen gas revive brain hypometabolism in neurodegeneration by SCFAs upregulation?. Eur J Clin Nutr 75, 212–213 (2021). https://doi.org/10.1038/s41430-020-0680-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41430-020-0680-x

This article is cited by

Search

Advanced search

Quick links